Page last updated: 2024-10-24

phototransduction, visible light

Definition

Target type: biologicalprocess

The sequence of reactions within a cell required to convert absorbed photons from visible light into a molecular signal. A visible light stimulus is electromagnetic radiation that can be perceived visually by an organism; for organisms lacking a visual system, this can be defined as light with a wavelength within the range 380 to 780 nm. [GOC:go_curators, ISBN:0198506732]

Phototransduction is the process by which light is converted into an electrical signal in photoreceptor cells of the eye. This complex process begins with the absorption of light by photopigments, specialized molecules that undergo conformational changes upon light absorption. In humans, the primary photopigments are rhodopsin in rod cells and cone opsins in cone cells.

Rhodopsin, a transmembrane protein embedded in the outer segment of rod cells, consists of a protein called opsin and a light-absorbing molecule called retinal. Retinal exists in two forms: cis-retinal and trans-retinal. In the dark, retinal is in its cis form, and rhodopsin is inactive. When light strikes the retina, it isomerizes cis-retinal to trans-retinal, causing a conformational change in the rhodopsin molecule. This change activates rhodopsin, triggering a cascade of biochemical reactions.

The activated rhodopsin initiates a signal transduction pathway involving a protein called transducin. Transducin is a heterotrimeric G protein composed of alpha, beta, and gamma subunits. When activated rhodopsin binds to transducin, it causes the alpha subunit of transducin to dissociate from the beta-gamma subunits. The alpha subunit, now carrying a bound GTP molecule, activates another protein called phosphodiesterase.

Phosphodiesterase is an enzyme that breaks down cyclic GMP (cGMP), a second messenger molecule involved in regulating the permeability of ion channels in the plasma membrane of photoreceptor cells. In the dark, cGMP levels are high, keeping these ion channels open. This allows sodium ions to flow into the cell, maintaining a depolarized state.

Upon light activation, phosphodiesterase hydrolyzes cGMP, causing a decrease in its concentration. This drop in cGMP levels leads to the closure of ion channels, reducing the flow of sodium ions into the cell. This results in hyperpolarization of the photoreceptor cell, which is the electrical signal that is transmitted to other neurons in the visual pathway.

The hyperpolarization signal travels along the optic nerve to the brain, where it is processed and interpreted as visual information.

The entire process of phototransduction is remarkably efficient, allowing us to see in a wide range of light conditions. In addition, the system is rapidly reset, allowing for continuous visual perception. This is achieved by a series of feedback mechanisms that deactivate rhodopsin, replenish cGMP, and return the photoreceptor cells to their resting state.'
"

Proteins (5)

ProteinDefinitionTaxonomy
RhodopsinA rhodopsin that is encoded in the genome of cow. [OMA:P02699, PRO:DNx]Bos taurus (cattle)
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'A cone cGMP-specific 3,5-cyclic phosphodiesterase subunit alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51160]Homo sapiens (human)
Guanine nucleotide-binding protein G(q) subunit alphaA guanine nucleotide-binding protein G(q) subunit alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P50148]Homo sapiens (human)
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit betaA rod cGMP-specific 3,5-cyclic phosphodiesterase subunit beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P35913]Homo sapiens (human)
Guanine nucleotide-binding protein subunit alpha-11A guanine nucleotide-binding protein subunit alpha-11 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P29992]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
dipyridamoledipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
1-methyl-3-isobutylxanthine1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES

3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
3-isobutyl-1-methylxanthine
madecassic acidmonocarboxylic acid;
pentacyclic triterpenoid;
tetrol
antioxidant;
plant metabolite
tadalafilbenzodioxoles;
pyrazinopyridoindole
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
evodiaminebeta-carbolines
nsc 889154-pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate): a tyrosyl-DNA phosphodiesterase inhibitor; structure in first source
ym-254890YM-254890: structure in first source
FR900359FR900359: G-protein inhibitor from Ardisia crenata sims that shows inhibition of platelet aggregation and decrease of blood pressurecyclodepsipeptide
sildenafilsildenafil : A pyrazolo[4,3-d]pyrimidin-7-one having a methyl substituent at the 1-position, a propyl substituent at the 3-position and a 2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl group at the 5-position.piperazines;
pyrazolopyrimidine;
sulfonamide
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
zaprinastzaprinast: anaphylaxis inhibitor; structuretriazolopyrimidines
vardenafilvardenafil : The sulfonamide resulting from formal condensation of the sulfo group of 4-ethoxy-3-(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one-2-yl)benzenesulfonic acid and the secondary amino group of 4-ethylpiperazine.imidazotriazine;
N-alkylpiperazine;
N-sulfonylpiperazine
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent